What does Jagsonpal Pharma do?
Jagsonpal Pharmaceuticals Ltd, established in 1978, manufactures and markets bulk drugs and pharmaceuticals, reporting net sales of ₹59 Cr and a net profit of ₹7 Cr for March 2025. The company has a market cap of ₹1,548 Cr and key metrics include a P/E ratio of 40.00 and a dividend yield of 0.86%.
Overview: Jagsonpal Pharmaceuticals Ltd is engaged in the manufacture and marketing of bulk drugs and pharmaceuticals, operating within the Pharmaceuticals & Biotechnology industry and categorized as a Small Cap company.History:
Incorporated in August 1978, Jagsonpal Pharmaceuticals has maintained its status as a manufacturer and marketer of pharmaceuticals. The latest quarterly results reported net sales and profit for March 2025.
Financial Snapshot:
Net Sales: 59 Cr (Quarterly Results - Mar 2025)
Net Profit: 7 Cr (Quarterly Results - Mar 2025)
Market Cap: Rs 1,548 Cr (Small Cap)
Key Metrics:
P/E: 40.00
Industry P/E: 35
Dividend Yield: 0.86%
Debt-Equity: -0.50
Return on Equity: 16.17%
Price to Book: 6.44
Contact Details:
Address: T-210 J, Shahpur Jat New Delhi New Delhi : 110049
Tel: 91-011-46181100/46109900
Email: nandita.singh@jagsonpal.com
Website: http://www.jagsonpal.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
